AGEN

$6.67+2.14%

AGENUS INC

Market Cap

$300M

Live price × SEC shares (Aug 4, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.54

60mo monthly vs SPY

P/E (TTM)

3.3

TTM to Jun 2026 · mkt cap / net income

P/S (TTM)

2.3

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

7.6

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	30,235	34,204	33,736	34,518	132,693
Cost of revenue	642	0	0	0	642
Research & development	23,596	7,511	11,822	14,759	57,688
Operating income	(4,545)	14,398	15,054	11,293	36,200
Interest expense	13,244	16,049	14,690	15,363	59,346
Net income	63,860	(10,632)	39,172	(604)	91,796
EPS (basic) ($)	2.00		1.03	(0.01)	—
EPS (diluted) ($)	1.94		1.02	(0.01)	—
Weighted avg. shares (basic)	31,886		37,941	41,338
Weighted avg. shares (diluted)	32,858		38,285	41,338

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 7, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

15 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 18, 2026 accepted 8:30 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Aug 13, 2026 accepted 1:30 AM ET	5.02Officer / director change	Document SEC ↗
Aug 11, 2026 accepted 8:30 PM ET	5.02Officer / director change	Document SEC ↗
Aug 6, 2026 accepted 11:52 AM ET	2.02Earnings release	Document SEC ↗
Jul 13, 2026 accepted 10:30 AM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jul 6, 2026 accepted 8:10 PM ET	1.01Material agreement	Document SEC ↗
Jun 23, 2026 accepted 2:14 PM ET	5.07Shareholder vote	Document SEC ↗
May 15, 2026 accepted 8:08 PM ET	5.02Officer / director change	Document SEC ↗
May 11, 2026 accepted 12:52 PM ET	2.02Earnings release	Document SEC ↗
Mar 26, 2026 accepted 12:24 PM ET	8.01Other events	Document SEC ↗